Rossari Biotech Limited — Updates, 17-01-2026: General Updates
17-01-2026 | 04:20 pm
17-01-2026 | 04:20 pm
Rossari Biotech's board approved Q3 & 9M results. Strategic move: greenfield specialty chemical plant in Saudi Arabia. Asset monetization: Kanjurmarg office sold for Rs. 25 Cr. Portfolio optimization: Bangladesh subsidiary closure approved, no operational impact.
No comments yet. Be the first to comment!
